Inhaled Fenoterol powder in asthma: a long term study.
A study was designed to assess the long term efficacy of Fenoterol powder in asthmatic children. The design included an initial assessment period and a further evaluation after six months, in which Fenoterol or placebo treatments were administered on consecutive days. Objective measurements were obtained from PEFR and FEV1. A diary record was kept to monitor compliance and side effects. A minimum dose of 200 mcg Fenoterol powder was prescribed three times per day. The bronchodilator action of Fenoterol was sustained after a period of six months, in the absence of significant side effects.
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004983:Ethanolamines / Q000008:administration & dosage*; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D010366:Peak Expiratory Flow Rate; D011208:Powders
D004983:Ethanolamines; D011208:Powders; D005280:Fenoterol